✦ LIBER ✦

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer

✍ Scribed by Yoon-Koo Kang; Min-Hee Ryu; Changhoon Yoo; Heung-Moon Chang; Jeong Hwan Yook; Sung Tae Oh; Byung Sik Kim; Tae Won Kim

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of 3-weekly docetaxel, cap

✍ Sun Jin Sym; Min-Hee Ryu; Hye Jin Kang; Sung Sook Lee; Heung-Moon Chang; Jae Lyu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 328 KB

Phase II study of docetaxel and cisplati

✍ Keon Woo Park; Jin Seok Ahn; Young Suk Park; Jeeyun Lee; Jung Hoon Kang; Joon Oh 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 223 KB

Phase II study of biweekly docetaxel and

✍ Chikara Kunisaki; Masazumi Takahashi; Hirochika Makino; Takashi Oshima; Shoichi 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 272 KB

Phase II study of docetaxel, capecitabin

✍ Yen-Shen Lu; Dar-Ren Chen; Ling-Min Tseng; Dah-Cherng Yeh; Shou-Tung Chen; Chia- 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

Phase II study of capecitabine and cispl

✍ Yu-Hong Li; Feng-Hua Wang; Wen-Qi Jiang; Xiao-Juan Xiang; Yan-Ming Deng; Guo-Qin 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 256 KB

Docetaxel and cisplatin in patients with

✍ Soh Saitoh; Yuh Sakata 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 119 KB